e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of the PDE4 inhibitor roflumilast n-oxide on the adherence of polymorphonuclear cells (PMNC) to bronchial epithelial cells (BEAS-2B) induced by non-typeable
Haemophilus influenzae
S. Boreo, L. Petecchia, F. Sabatini, M. Silvestri, G. Rossi (Genoa, Italy)
Source:
Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Session:
Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Session type:
E-Communication Session
Number:
422
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Boreo, L. Petecchia, F. Sabatini, M. Silvestri, G. Rossi (Genoa, Italy). Effects of the PDE4 inhibitor roflumilast n-oxide on the adherence of polymorphonuclear cells (PMNC) to bronchial epithelial cells (BEAS-2B) induced by non-typeable
Haemophilus influenzae
. Eur Respir J 2009; 34: Suppl. 53, 422
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
SABATINI Federica - 12.09.2009 12:57
da una amica solidale!!!!
In BOCCA AL LUPO!!!!!!!!!!!
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Effect of roflumilast N-oxide on non-typable
haemophilus influenzae
(NTHi) interaction with human airway epithelial A549 cells
Source: Annual Congress 2011 - Epithelial cell biology
Year: 2011
Roflumilast N-oxide (RNO) decreases neutrophil adhesion to human bronchial epithelial cells (BEAS-2B) induced by cigarette smoke condensate (CSC)
in vitro
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010
Roflumilast N-oxide (RNO) alleviates from RSV-induced loss of ciliated cells and enhanced MUC5AC in differentiated human bronchial epithelial cells (D-HBE)
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
Exposure of a bronchial epithelial cell line (BEAS-2B) to
haemophilus influenzae
(NTHi) lysate increases TLR-2 and TNF-α synthesis and results in an enhanced PMN adherence to epithelial cells
Source: Annual Congress 2008 - Airway infection and host defence
Year: 2008
Modulation of TNFα-induced ICAM-1 expression in a human bronchial epithelial cell line (Beas-2B) by roflumilast N-oxide (RNO), salmeterol (Sal) and budesonide (Bud)
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II
Year: 2007
Effect of clarithromycin on rhinovirus-16 infection in A549 cells
Source: Eur Respir J 2006; 27: 12-19
Year: 2006
Effects of PDE4 inhibitors on eotaxin-3 (CCL26) expression in lung epithelial cells
Source: Annual Congress 2009 - Epithelial cell biology
Year: 2009
Attenuating effect of tiotropium bromide on IL-8 production from human bronchial epithelial cells, BEAS-2B
in vitro
Source: Annual Congress 2009 - Epithelial cell biology
Year: 2009
Effects of IL-4 and neutrophil defensins (HNP1-3) on differentiation of primary bronchial epithelial cells (PBEC)
Source: Annual Congress 2007 - Epithelial networks in the airways
Year: 2007
The PDE4 inhibitor roflumilast N-oxide partly restored cigarette smoke (CS)-induced tight junction disassembly in human airway epithelial cells (Calu-3) – role of MAPK
Source: Annual Congress 2008 - Basic science in asthma and COPD II
Year: 2008
In vitro
modulation of the cytokine-induced human bronchial epithelial cell (HBEC) functions by ciclesonide (CIC)
Source: Eur Respir J 2004; 24: Suppl. 48, 346s
Year: 2004
Secretory leukoprotease inhibitor (SLPI) is removed from media of primary bronchial epithelial cells (PBEC) in the presence of neutrophil elastase (NE)
Source: Eur Respir J 2005; 26: Suppl. 49, 554s
Year: 2005
Effect of phosphodiesterase IV inhibitors on eotaxin expression in bronchial epithelial cells – Comparison between immortalized and primary line
Source: Annual Congress 2011 - Lung cell biology
Year: 2011
Cytokine-induced production of eotaxin-3 by human lung epithelial cells is inhibited by levocetirizine
Source: Eur Respir J 2005; 26: Suppl. 49, 98s
Year: 2005
The PDE4 inhibitor roflumilast N-oxide partly reversed TGFß1-induced changes in collagen I and E-cadherin expression in human airway epithelial cells
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD
Year: 2008
Inhibitory activity of fluticasone propionate (FP), on the constitutive or cytokine-induced bronchial epithelial cell (HBECs) functions
in vitro
Source: Eur Respir J 2003; 22: Suppl. 45, 76s
Year: 2003
Protective effect of MAPK inhibitors and budesonide against apoptosis induced by TGF-β in primary cultures of human bronchial epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 394s
Year: 2003
Resveratrol impairs cytokine release from human airway smooth muscle cells (HASMCs) and alveolar macrophages (AM) in COPD
Source: Annual Congress 2009 - Models of chronic airways disease and therapy
Year: 2009
Reduction of rhinovirus 16-induced epithelial ICAM-1 expression by cilomilast (Ariflo)
Source: Eur Respir J 2003; 22: Suppl. 45, 395s
Year: 2003
Proteasome inhibitors modulate chemokine production in lung epithelial and monocytic cells
Source: Eur Respir J 2004; 24: 40-48
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept